
Keywords: ALNC; axillary lymph node cells; CFA; complete Freund's adjuvants; CIA; collagen-induced arthritis; COLL II; bovine type II collagen; IBD; inflammatory bowel disease; id; intradermal; IFA; incomplete Freund's adjuvants; IFN-γ; interferon gamma; IL; inter